Effect of B-cell depletion on vaginal microbiota and mucosal immunity
B 细胞耗竭对阴道微生物群和粘膜免疫的影响
基本信息
- 批准号:10374759
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-19 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AgeAnimalsAntibodiesAreaAtopobium vaginaeAutoantibodiesAutoimmune DiseasesB-LymphocytesBacteriaBindingBiologicalBiologyCaringCell CountCellsCervicalClinicalCommunitiesDataDiagnosisDropsEnrollmentEnvironmentEpithelial CellsEpitopesEscherichia coliEtiologyExperimental ModelsFemale genitaliaGardnerella vaginalisGrantHomeostasisHumanImmuneImmunityImmunoglobulin AImmunoglobulin GImmunoglobulin-Secreting CellsImmunoglobulinsImmunologic MarkersInfection ControlInflammationInflammatoryIntravenous ImmunoglobulinsKnowledgeLactobacillusLeadLow Birth Weight InfantMS4A1 geneMeasurementMeasuresMonoclonal AntibodiesMorbidity - disease rateMucosal Immune ResponsesMucosal ImmunityMucositisMucous MembraneMusObservational StudyOutcomePainPlasma CellsPlayPopulationPregnancyPremature BirthRegulationReproductive HealthRiskRoleSamplingSecretory Immunoglobulin ASexually Transmitted DiseasesSpontaneous abortionStreptococcusStreptococcus Group BSurfaceSymptomsTestingTimeVaginaVaginal DischargeVaginitisWomananti-CD20chemokinecohortcytokinedensitydesigndysbiosisexperienceexperimental studygut microbiotahigh riskhost-microbe interactionsimmunoregulationimplantationin vivoineffective therapiesinflammatory markermicrobial communitymicrobiomemicrobiotanovelnovel strategiespathobiontreproductive outcomereproductive tractrestorationrituximabtositumomabvaginal fluidvaginal lactobacillivaginal microbiomevaginal microbiotavaginal mucosa
项目摘要
PROJECT SUMMARY
The vaginal microbiome plays a significant role in reproductive health outcomes, influencing a woman’s chances
of pregnancy implantation, miscarriage, low birth weight, preterm delivery, and acquisition of sexually transmitted
infections. While many studies have shown that changes in the female genital tract (FGT) microbiota drive
changes in the mucosal immune environment, there are few studies that have explored the alternate possibility:
that changes in host mucosal immunity determine the composition of the vaginal microbial community. We have
described a Lactobacillus-deficient, inflammatory vaginitis in women treated with rituximab, an anti-CD20
antibody which leads to systemic B-cell depletion. This observation led us to hypothesize that B-cells and
vaginal fluid antibodies regulate the composition of the vaginal microbiota, controlling levels of
pathobionts such as E. coli and Group B streptococcus and facilitating Lactobacillus dominance.
Although associations between B-cells, antibodies and microbiota have been described in the gut, this is an
unexplored area in the female genital tract. Our proposed project is novel in both exploring the role of B-cells
and antibodies in regulation of vaginal microbiota, but also in using clinical rituximab treatment as an in vivo
experimental model. This exploratory grant has potential to identify highly significant biologic mechanisms for
regulation of FGT microbiota and mucosal inflammation, both of which are associated with adverse reproductive
health outcomes. To test our hypothesis, we propose an observational study comparing women treated with
rituximab to healthy controls to identify the role of B-cells in determining the composition of the vaginal microbiota.
In Aim 1 we will compare the vaginal microbiota, cervical immune cells, vaginal fluid immunoglobulins and
soluble markers of inflammation between 40 women being treated with rituximab to 40 healthy controls. We will
also compare these markers between women being treated with rituximab with inflammatory vaginitis and those
without. In Aim 2, we will assess the causal relationship with B-cell depletion by comparing changes in our
measured analytes over time in women who are 1) starting, 2) stopping and 3) stable on treatment with rituximab
(n = 10 in each group). Our local vaginal measurements of immune cell populations and soluble markers will be
compared with systemic measurements of B-cell numbers and IgG levels. Using rituximab treatment as an in
vivo experimental model will provide a novel opportunity to examine the role of systemic immunity in regulating
the vaginal microbiota and mucosal immune responses, which will lead to broader understanding of both vaginal
and systemic mucosal immunity.
项目摘要
阴道微生物组在生殖健康结果中起着重要作用,影响着女性的机会
怀孕植入,流产,低出生体重,早产,和获得性传播疾病
感染.虽然许多研究表明,女性生殖道(FGT)微生物群的变化
粘膜免疫环境的变化,很少有研究探索了替代的可能性:
宿主粘膜免疫力的变化决定了阴道微生物群落的组成。我们有
描述了一种使用利妥昔单抗(一种抗CD20抗体)治疗的女性乳杆菌缺陷性炎症性阴道炎,
抗体导致全身性B细胞耗竭。这一观察使我们假设B细胞和
阴道液抗体调节阴道微生物群的组成,控制
致病菌如E.大肠杆菌和B群链球菌,促进乳酸杆菌优势。
尽管已经描述了肠道中B细胞、抗体和微生物群之间的联系,但这是一个不确定因素。
女性生殖道中未被探索的区域。我们提出的项目在探索B细胞的作用和
和抗体调节阴道微生物群,而且在使用临床利妥昔单抗治疗作为体内
实验模型这项探索性资助有可能确定高度重要的生物学机制,
FGT微生物群和粘膜炎症的调节,两者都与不良生殖
健康成果。为了验证我们的假设,我们提出了一项观察性研究,
利妥昔单抗与健康对照组比较,以确定B细胞在确定阴道微生物群组成中的作用。
在目标1中,我们将比较阴道微生物群、宫颈免疫细胞、阴道液免疫球蛋白和阴道分泌物免疫球蛋白。
用利妥昔单抗治疗的40名妇女与40名健康对照之间的可溶性炎症标志物。我们将
我还比较了用利妥昔单抗治疗的炎症性阴道炎妇女和
没有.在目标2中,我们将通过比较我们的
在1)开始、2)停止和3)稳定接受利妥昔单抗治疗的女性中随时间推移测量的分析物
(每组n = 10)。我们对免疫细胞群和可溶性标记物的局部阴道测量将是
与B细胞数量和IgG水平的系统测量相比。使用利妥昔单抗治疗作为
体内实验模型将提供一个新的机会,检查系统免疫的作用,在调节
阴道微生物群和粘膜免疫反应,这将导致更广泛的理解,阴道和粘膜的免疫反应。
和全身粘膜免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline M Mitchell其他文献
Effect of the vaginal live biotherapeutic LACTIN-V (emLactobacillus crispatus/em CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial
阴道活菌治疗剂 LACTIN-V(嗜酸乳杆菌crispatus/CTV-05)对南非 HIV 感染高风险女性阴道微生物群和生殖道炎症的影响:一项 2 期、随机、安慰剂对照试验
- DOI:
10.1016/j.lanmic.2024.101037 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:20.400
- 作者:
Anke Hemmerling;Caroline M Mitchell;Suuba Demby;Musie Ghebremichael;Joseph Elsherbini;Jiawu Xu;Nondumiso Xulu;Johnathan Shih;Krista Dong;Vaneshree Govender;Vanessa Pillay;Nasreen Ismail;Gardenia Casillas;Jayajothi Moodley;Agnes Bergerat;Tess Brunner;Lenine Liebenberg;Sinaye Ngcapu;Ian Mbano;Laurel Lagenaur;Craig R Cohen - 通讯作者:
Craig R Cohen
Caroline M Mitchell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline M Mitchell', 18)}}的其他基金
Vaginal microbiota transplant to promote Lactobacillus-dominant cervicovaginal communities
阴道微生物群移植促进以乳杆菌为主的宫颈阴道群落
- 批准号:
10366355 - 财政年份:2021
- 资助金额:
$ 25.2万 - 项目类别:
Novel mechanisms of pathogenesis in idiopathic vaginitis
特发性阴道炎发病机制的新机制
- 批准号:
9107790 - 财政年份:2015
- 资助金额:
$ 25.2万 - 项目类别:
Novel mechanisms of pathogenesis in idiopathic vaginitis
特发性阴道炎发病机制的新机制
- 批准号:
8969791 - 财政年份:2015
- 资助金额:
$ 25.2万 - 项目类别:
Female Genital Innate Immune Response to Vaginal Microbiota
女性生殖器对阴道微生物群的先天免疫反应
- 批准号:
8447048 - 财政年份:2010
- 资助金额:
$ 25.2万 - 项目类别:
Female Genital Innate Immune Response to Vaginal Microbiota
女性生殖器对阴道微生物群的先天免疫反应
- 批准号:
8636983 - 财政年份:2010
- 资助金额:
$ 25.2万 - 项目类别:
Female Genital Innate Immune Response to Vaginal Microbiota
女性生殖器对阴道微生物群的先天免疫反应
- 批准号:
8049622 - 财政年份:2010
- 资助金额:
$ 25.2万 - 项目类别:
Female Genital Innate Immune Response to Vaginal Microbiota
女性生殖器对阴道微生物群的先天免疫反应
- 批准号:
7869806 - 财政年份:2010
- 资助金额:
$ 25.2万 - 项目类别:
Female Genital Innate Immune Response to Vaginal Microbiota
女性生殖器对阴道微生物群的先天免疫反应
- 批准号:
8239587 - 财政年份:2010
- 资助金额:
$ 25.2万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Training Grant